Gene Polymorphism in Tinea Versicolor

Clinical Trial Summary

Blood samples will be taken from cases presenting with recurrent tinea versicolor , after confirmation of diagnosis by wood's light and KOH examination, for the detection of gene polymorphism in IL17 A and IL17 F. In addition , serum samples from patients and controls will be tested for 25(OH)2 D3

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05067699` - Vitamin D Level in Recurrent PV

See also

Status

Clinical Trial

Phase

Recruiting

NCT05067699 - Vitamin D Level in Recurrent PV

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04769804
Study type	Observational
Source	Kasr El Aini Hospital
Contact	Rana Hilal, MD
Phone	01001488869
Email	rana.hilal@kasralainy.edu.eg
Status	Recruiting
Phase
Start date	November 1, 2019
Completion date	November 1, 2021

Gene Polymorphism in Tinea Versicolor

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms